Drug Information
Drug (ID: DG02144) and It's Reported Resistant Information
| Name |
Gemcitabine/Huaier
|
||||
|---|---|---|---|---|---|
| Synonyms |
Gemcitabine/Huaier
Click to Show/Hide
|
||||
| Indication |
In total 1 Indication(s)
|
||||
Type(s) of Resistant Mechanism of This Drug
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-02: Benign/in-situ/malignant neoplasm
| Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Key Molecule: Forkhead box protein M1 (FOXM1) | [1] | |||
| Sensitive Disease | Pancreatic ductal adenocarcinoma [ICD-11: 2C10.0] | |||
| Molecule Alteration | Expressiom | Up-regulation |
||
| Experimental Note | Discovered Using In-vivo Testing Model | |||
| In Vivo Model | nude mice injected Panc-1 cells | Mus musculus | ||
| Experiment for Drug Resistance |
Tumor evaluation assay | |||
| Mechanism Description | Overall, this study illustrates that Huaier augments the tumor-killing effect of gemcitabine through suppressing the stemness induced by gemcitabine in a FoxM1-dependent way. These results indicate that Huaier can be applied to overcome gemcitabine resistance. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
